Feasibility Study on the Integration of AR-based Entertainment and Distraction for Isolated Patients with Uveal Melanoma

Feasibility Study on the Integration of AR-based Entertainment and Distraction for Isolated Patients with Uveal Melanoma - ARUDIPA

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00040066

Enrollment

Registered

2026-04-22

Start date

2026-06-22

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C69.3

Interventions

Group 1: A monocentric, exploratory feasibility study without randomization or blinding. After written informed consent, participants receive the AR video glasses (VITURE Pro XR Glasses) in their hos

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Inpatient brachytherapy with radiation protection-related isolation Capacity to provide informed consent Sufficient German language skills (written and spoken) Availability of a compatible personal mobile device (smartphone, tablet, or notebook with USB-C port with DisplayPort functionality or Lightning connector) Written informed consent to participate in the study

Exclusion criteria

Exclusion criteria: Neurological conditions precluding safe use of the AR glasses (e.g., photosensitive epilepsy, dementia, delirium/transitional syndrome) Severe psychiatric disorders (e.g., schizophrenia) Strong susceptibility to nausea (e.g., motion sickness) or known balance disorders

Design outcomes

Primary

Measure	Time frame
Satisfaction with the intervention (school grading scale 1–6); user satisfaction, acceptance, willingness to reuse and recommend, and attitude towards innovation in medicine (self-formulated items, 5-point Likert scale); perceived distraction from the hospital situation, sense of privacy, relaxation, and boredom (self-formulated items, 5-point Likert scale); feasibility of the intervention (systematic documentation of technical and organisational problems by study personnel); documentation of adverse events (AEs) associated with use of the AR glasses.	—

Measure

Time frame

Satisfaction with the intervention (school grading scale 1–6); user satisfaction, acceptance, willingness to reuse and recommend, and attitude towards innovation in medicine (self-formulated items, 5-point Likert scale); perceived distraction from the hospital situation, sense of privacy, relaxation, and boredom (self-formulated items, 5-point Likert scale); feasibility of the intervention (systematic documentation of technical and organisational problems by study personnel); documentation of adverse events (AEs) associated with use of the AR glasses.

—

Secondary

Measure	Time frame
Self-reported content usage (content category, duration, and frequency of use); use of specific technical features (e.g., dimming function); AR-induced symptoms such as nausea, dizziness, and headaches / simulator sickness (self-formulated dichotomous items); pain intensity (Numerical Rating Scale, 0–10); prior experience with XR and gaming (self-formulated items).	—

Countries

Germany

Contacts

Public ContactStefan Liszio

Zentrum für virtuelle und erweiterte Realität in der Medizin / Universitätsmedizin Essen

stefan.liszio@ume.de+49 201 723 1907

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Aug 10, 2026